EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 27-Oct-2026 14:17 ET (27-Oct-2026 18:17 GMT/UTC)

Running marathons with type 1 diabetes can be safe, shows small study using continuous glucose monitoring devices

European Association for the Study of Diabetes
Reports and Proceedings

**Note this is an early release from the Annual Meeting of the European Association for the Study of Diabetes [EASD]. Please credit the meeting when using this research**

New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28th – Oct 2nd) shows, with the use of continuous glucose monitoring (CGM) devices people with type 1 diabetes can complete a marathon safely and achieve finishing times similar to runners without diabetes. The study is conducted by Michał Kulecki, Dr Andrzej Gawrecki, and colleagues at Poznan University of Medical Sciences and Raszeja City Hospital, Poznan, Poland.

Meeting: Annual Meeting of the European Association for the Study of Diabetes (EASD)

Deep learning helps scientists design materials that can both detect and capture toxic sulfur gases

Shenyang Agricultural University Collaborative Journals
Peer-Reviewed Publication

Toxic sulfur-containing gases such as hydrogen sulfide and sulfur oxides are serious concerns for human health, industrial safety and the environment. Developing materials that can not only detect these gases but also capture them efficiently is therefore an important goal. Yet identifying materials that balance strong adsorption with a useful sensing response remains challenging.

Proven radiotracer highly effective in detecting rare, aggressive kidney cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

Renal medullary carcinoma (RMC) demonstrates strong uptake of the radiotracer ¹⁸F-FDG, distinguishing it from other types of kidney cancer which often have more variable uptake. ¹⁸F-FDG PET/CT was found to be highly effective even after systemic treatment and detected additional metastases missed by conventional anatomic imaging, providing a more complete picture of how far the cancer had spread. This research was published in the September issue of The Journal of Nuclear Medicine.

Journal: Journal of Nuclear Medicine

Scientists map the hidden protein network that helps red blood cells adapt to oxygen

University of Colorado Anschutz
Peer-Reviewed Publication

They account for nearly 83% of all cells in the human body, yet red blood cells are often portrayed as little more than bags of hemoglobin ferrying oxygen from the lungs to the heart and beyond. But new research from the University of Colorado Anschutz reveals that they are vastly more complex with far reaching consequences for health, exercise and fitness.

Journal: Blood

Countering motor neuron degeneration with base editing

Center for iPS Cell Research and Application - Kyoto University
Peer-Reviewed Publication

A team of researchers led by Professor Haruhisa Inoue (Department of Clinical Application, CiRA, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base editing can correct a disease-causing genetic mutation and alleviate neurodegeneration in hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P), providing proof of concept for a precision gene therapy for inherited motor neuron diseases.

Large study finds no added risk of rare artery tear following chiropractic neck care

University Hospitals Cleveland Medical Center
Peer-Reviewed Publication

Getting your neck adjusted by a chiropractor does not appear to raise the risk of a rare but serious artery injury, according to a large observational study from a multidisciplinary collaboration including researchers at University Hospitals Cleveland Medical Center.

Journal: Chiropractic & Manual Therapies

Researchers uncover how aggressive breast cancer may spread to the brain

Wake Forest University School of Medicine
Peer-Reviewed Publication

Wake Forest University School of Medicine researchers identified SIRPα as a protein that may help triple-negative breast cancer spread to the brain and evade immune defenses, offering a potential target for future treatments.

Journal: Neuro-Oncology
Funder: American Society for Radiation Oncology, Lewis-Michael Miracle Fund, American Cancer Society

University of Cincinnati emergency medicine physicians safely eliminate thousands of unnecessary CT scans

University of Cincinnati
Peer-Reviewed Publication

Meta Description (160-250 characters): A University of Cincinnati emergency medicine quality improvement campaign avoids 3,500-plus head and cervical spine CT scans, saving $6.2 million in patient charges, more than 14,000 hours of waiting time and significant radiation exposure with no patient harm.

Journal: Western Journal of Emergency Medicine

ARDD 2026 brings global pharma, FDA leaders and longevity science pioneers to Harvard October 1–3

InSilico Medicine
Meeting Announcement

ARDD 2026 will convene senior leaders from Novartis, Eli Lilly, Pfizer, Takeda, Menarini, GSK, AstraZeneca, Novo Nordisk and other global pharmaceutical companies alongside leading academics, regulators, investors and biotechnology innovators at Harvard University from October 1–3.

Newly announced program highlights include a pharmaceutical chief executive panel moderated by TIME Senior Health Correspondent Alice Park; an FDA and ARPA-H discussion on aligning clinical trials with regulatory mandates; and presentations from the 11 XPRIZE Healthspan finalist teams preparing aging interventions for Phase 2 clinical trials.

Dedicated forums will examine AI-enabled drug discovery, pet and animal longevity, and virtual cell models that capture biological change and aging over time. The three-day program will span aging biology, clinical development, pharmaceutical R&D, regulation, investment and the translation of longevity science into new medicines.

Now in its 13th year, ARDD brings together the scientific, commercial and regulatory leaders shaping longevity biotechnology. The meeting will take place at the David Rubenstein Treehouse at Harvard University in Boston.

Meeting: Aging Research & Drug Discovery Annual Meeting